A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis
Top Cited Papers
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 127 (2) , 476-484
- https://doi.org/10.1053/j.gastro.2004.05.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Incidence and natural history of small esophageal varices in cirrhotic patientsJournal of Hepatology, 2003
- Current management of portal hypertensionJournal of Hepatology, 2003
- Natural History of Cirrhotic Patients With Small Esophageal Varices: A Prospective StudyAmerican Journal of Gastroenterology, 2000
- Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosisEuropean Journal of Gastroenterology & Hepatology, 1999
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed ratsJournal of Hepatology, 1991
- Beta-Adrenergic–Antagonist Drugs in the Prevention of Gastrointestinal Bleeding in Patients with Cirrhosis and Esophageal VaricesNew England Journal of Medicine, 1991
- Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.Journal of Clinical Investigation, 1991
- Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.Gut, 1990
- Prediction of variceal hemorrhage by esophageal endoscopyGastrointestinal Endoscopy, 1981